Schedule 13G ownership disclosure

Fennec Pharmaceuticals Inc

Security class unavailable · CUSIP: 31447P100

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-044914
Form type
SC 13G/A
Filer
DG Capital Management, LLC
CIK
CIK 1512716
Filed
Nov 12, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub